Service

Meet Oncodesign in person this spring
Corporate
Service
27/04/2022

[Congress] Meet Oncodesign in person this spring

Check out where to meet Oncodesign this spring... surely we can arrange a meeting somewhere.

Oncology Webinar
Service
05/04/2022

[EN] How to Better Optimize an Oncology Drug Discovery Program

Watch this oncology webinar on preclinical pharmacology, covering all step of the drug discovery journey from target validation to clinical studies...

Scientific Resources | Oncodesign
Service
28/03/2022

Scientific Posters | AACR 2022

Find all 4 posters that are presented during AACR 2022. They unveil our expertise in oncology using our scientific know-how (medicinal chemistry, radio-imaging, in vivo model and microbiome)

[CONGRESS] Microbiome & Probiotics
Service
18/03/2022

[Congress] AACR Annual Meeting | 8-13 April 2022

Meet us in person at the Annual Meeting of the AACR in New Orleans!

Oncology Webinar
Service
16/03/2022

[Webinar] How to better optimize an oncology drug discovery program

Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.

[CONGRESS] Microbiome & Probiotics
Service
14/03/2022

[CONGRESS] Microbiome & Probiotics, 29-30 March 2022

Meet us at the Microbiome & Probiotics congress in San Diego | March 2022. Explore our expertise in assessing the role of microbiome in drug discovery

Drive-Biologics - Discovery & Developement | Oncodesign
Service
24/02/2022

Abzena, Alira Health and Oncodesign launch DRIVE-Biologics to support access to specialist services

Abzena x Alira Health x Oncodesign: unveil unique integrated solution with specialist services, from biologics discovery to clinical & commercial manufacturing

Service
18/02/2022

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

Published in Science Advances: the preclinical development program of exoASO-STAT6, a novel, engineered #exosome precision medicine candidate for the treatment of macrophage-rich tumors.

Service
14/01/2022

[Congress] Microbiome Movement Drug Development

Oncodesign will be at the digital event Microbiome Movement Drug Development. Take the opportunity to learn more about SOLO Microbiome.

Service
11/12/2021

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections

SARS-CoV-2; antiviral drug combination; hepatitis C virus; hepatitis E virus; human immunodeficiency virus; influenza A virus; interferon-alpha.

Service
07/12/2021

[EN] Preclinical Models for Microbiome Research in Oncology and Inflammatory Diseases

Learn how current in vivo preclinical models meet the needs of microbiome research and innovation while outlining their limitations and the challenges still to be overcome in this growing field.

Service
16/11/2021

[EN] How Rodent and NHP Models Support COVID-19 Treatment Development

Learn how to select the most appropriate COVID-19 animal model for preclinical studies in this webinar